NCT04530890
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer No drug interventions basic_science Not Available recruiting NCT04229121
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT06495554
Danish Vulva Cancer Recurrence Study No drug interventions other Not Available not_yet_recruiting NCT05601505
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer No drug interventions treatment 2 recruiting NCT05787197
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases No drug interventions Not Available Not Available recruiting NCT04457297
Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection treatment 3 recruiting NCT06404593
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases No drug interventions Not Available Not Available completed NCT05161585
Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study No drug interventions diagnostic Not Available unknown_status NCT05529615
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer No drug interventions treatment Not Available recruiting NCT04276337
Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy No drug interventions Not Available Not Available unknown_status NCT04511559
Methylation Analysis of Circulating Tumor DNA in Gastric Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03615170
Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer No drug interventions Not Available Not Available unknown_status NCT03770299
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease treatment 2 withdrawn NCT05427617
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer Not Available Not Available completed NCT05801263
ctDNA Methylation for Epithelial Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT06479460
Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients No drug interventions Not Available Not Available recruiting NCT03748680
IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer treatment 2 recruiting NCT04434040
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) No drug interventions treatment 2 active_not_recruiting NCT05167604
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC No drug interventions Not Available Not Available recruiting NCT04456972
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. No drug interventions diagnostic Not Available completed NCT05390112
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization No drug interventions Not Available Not Available recruiting NCT05969938
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology No drug interventions Not Available Not Available recruiting NCT05415787
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer. No drug interventions Not Available Not Available completed NCT05027828
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT05598528
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) No drug interventions Not Available Not Available recruiting NCT03750175
OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - No drug interventions Not Available Not Available completed NCT04560270
CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer No drug interventions diagnostic Not Available completed NCT06434896
Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial No drug interventions diagnostic Not Available recruiting NCT03688035
Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients No drug interventions Not Available Not Available unknown_status NCT04966663
Using ctDNA to Determine Therapies for Lung Cancer No drug interventions treatment 2 recruiting NCT03737539
Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA) No drug interventions Not Available Not Available recruiting NCT05079074
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer No drug interventions Not Available Not Available completed NCT02620527
Concordance Between ctDNA Assay and FoundationOne No drug interventions Not Available Not Available completed NCT05801276
ctDNA Methylation for Detecting Ovarian Cancer No drug interventions Not Available Not Available recruiting NCT03481101
WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC No drug interventions diagnostic Not Available unknown_status NCT05495672
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules No drug interventions treatment Not Available recruiting NCT04555369
The Value of ctDNA on Chemotherapy Efficacy for mCRC No drug interventions basic_science Not Available recruiting